Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| pericyte | 21 studies | 36% ± 21% | |
| astrocyte | 19 studies | 36% ± 16% | |
| endothelial cell | 17 studies | 25% ± 11% | |
| endothelial cell of lymphatic vessel | 17 studies | 32% ± 11% | |
| smooth muscle cell | 13 studies | 33% ± 14% | |
| fibroblast | 12 studies | 27% ± 10% | |
| capillary endothelial cell | 10 studies | 28% ± 8% | |
| myofibroblast cell | 4 studies | 24% ± 10% | |
| endothelial cell of vascular tree | 4 studies | 21% ± 2% | |
| oligodendrocyte precursor cell | 4 studies | 34% ± 19% | |
| melanocyte | 4 studies | 55% ± 26% | |
| connective tissue cell | 3 studies | 21% ± 3% | |
| glial cell | 3 studies | 41% ± 25% | |
| type II pneumocyte | 3 studies | 20% ± 3% | |
| Mueller cell | 3 studies | 28% ± 3% |
Insufficient scRNA-seq data for expression of EDNRB at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 92% | 4636.64 | 2442 / 2642 | 99% | 215.04 | 695 / 705 |
| kidney | 96% | 3795.02 | 85 / 89 | 79% | 82.43 | 714 / 901 |
| skin | 70% | 1456.81 | 1258 / 1809 | 98% | 381.04 | 461 / 472 |
| thymus | 100% | 4918.80 | 651 / 653 | 60% | 24.94 | 363 / 605 |
| adrenal gland | 100% | 4223.41 | 257 / 258 | 57% | 27.11 | 131 / 230 |
| prostate | 96% | 3339.54 | 235 / 245 | 25% | 6.48 | 126 / 502 |
| lung | 100% | 8289.62 | 576 / 578 | 14% | 3.60 | 156 / 1155 |
| breast | 100% | 7206.51 | 459 / 459 | 12% | 2.66 | 133 / 1118 |
| bladder | 100% | 2839.76 | 21 / 21 | 8% | 2.36 | 41 / 504 |
| liver | 81% | 1565.93 | 184 / 226 | 25% | 5.84 | 101 / 406 |
| adipose | 100% | 9740.63 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 204.99 | 79 / 80 |
| heart | 97% | 3325.40 | 832 / 861 | 0% | 0 | 0 / 0 |
| intestine | 87% | 1794.17 | 837 / 966 | 9% | 1.94 | 47 / 527 |
| uterus | 88% | 2211.20 | 149 / 170 | 5% | 1.32 | 25 / 459 |
| spleen | 84% | 1741.13 | 202 / 241 | 0% | 0 | 0 / 0 |
| stomach | 64% | 1051.72 | 228 / 359 | 16% | 3.60 | 45 / 286 |
| esophagus | 63% | 1432.12 | 913 / 1445 | 15% | 4.15 | 27 / 183 |
| pancreas | 51% | 702.75 | 166 / 328 | 22% | 6.35 | 40 / 178 |
| blood vessel | 59% | 1229.54 | 789 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 56% | 923.02 | 447 / 803 | 0% | 0 | 0 / 0 |
| ovary | 28% | 539.57 | 50 / 180 | 4% | 1.62 | 19 / 430 |
| peripheral blood | 2% | 22.12 | 15 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007194 | Biological process | negative regulation of adenylate cyclase activity |
| GO_0019934 | Biological process | cGMP-mediated signaling |
| GO_0070294 | Biological process | renal sodium ion absorption |
| GO_0030202 | Biological process | heparin metabolic process |
| GO_1990839 | Biological process | response to endothelin |
| GO_0072112 | Biological process | podocyte differentiation |
| GO_0060406 | Biological process | positive regulation of penile erection |
| GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
| GO_0019722 | Biological process | calcium-mediated signaling |
| GO_0001755 | Biological process | neural crest cell migration |
| GO_0014043 | Biological process | negative regulation of neuron maturation |
| GO_0032341 | Biological process | aldosterone metabolic process |
| GO_0014070 | Biological process | response to organic cyclic compound |
| GO_0035812 | Biological process | renal sodium excretion |
| GO_0002027 | Biological process | regulation of heart rate |
| GO_0001934 | Biological process | positive regulation of protein phosphorylation |
| GO_0006885 | Biological process | regulation of pH |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_1904383 | Biological process | response to sodium phosphate |
| GO_0060070 | Biological process | canonical Wnt signaling pathway |
| GO_0042045 | Biological process | epithelial fluid transport |
| GO_0051248 | Biological process | negative regulation of protein metabolic process |
| GO_0097018 | Biological process | renal albumin absorption |
| GO_0048066 | Biological process | developmental pigmentation |
| GO_0030318 | Biological process | melanocyte differentiation |
| GO_0048265 | Biological process | response to pain |
| GO_0043066 | Biological process | negative regulation of apoptotic process |
| GO_0002001 | Biological process | renin secretion into blood stream |
| GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
| GO_0050678 | Biological process | regulation of epithelial cell proliferation |
| GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
| GO_0007422 | Biological process | peripheral nervous system development |
| GO_0160093 | Biological process | chordate pharynx development |
| GO_0071222 | Biological process | cellular response to lipopolysaccharide |
| GO_0031620 | Biological process | regulation of fever generation |
| GO_0035645 | Biological process | enteric smooth muscle cell differentiation |
| GO_0008284 | Biological process | positive regulation of cell population proliferation |
| GO_0086100 | Biological process | endothelin receptor signaling pathway |
| GO_0061028 | Biological process | establishment of endothelial barrier |
| GO_0010467 | Biological process | gene expression |
| GO_0048246 | Biological process | macrophage chemotaxis |
| GO_0042311 | Biological process | vasodilation |
| GO_0042310 | Biological process | vasoconstriction |
| GO_0014826 | Biological process | vein smooth muscle contraction |
| GO_0007399 | Biological process | nervous system development |
| GO_0035810 | Biological process | positive regulation of urine volume |
| GO_0097402 | Biological process | neuroblast migration |
| GO_0070588 | Biological process | calcium ion transmembrane transport |
| GO_0048484 | Biological process | enteric nervous system development |
| GO_0007497 | Biological process | posterior midgut development |
| GO_0071806 | Biological process | protein transmembrane transport |
| GO_0007166 | Biological process | cell surface receptor signaling pathway |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0031965 | Cellular component | nuclear membrane |
| GO_0031702 | Molecular function | type 1 angiotensin receptor binding |
| GO_0017046 | Molecular function | peptide hormone binding |
| GO_0004962 | Molecular function | endothelin receptor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | EDNRB |
| Protein name | Endothelin receptor type B (ET-B) (ET-BR) (Endothelin receptor non-selective type) Endothelin receptor type B (Endothelin receptor non-selective type) |
| Synonyms | ETRB |
| Description | FUNCTION: Non-specific receptor for endothelin 1, 2, and 3. Mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. . |
| Accessions | ENST00000626030.1 [P24530-2] ENST00000646605.1 [P24530-1] ENST00000377211.8 [P24530-3] ENST00000645696.1 A0A2R8YGF7 ENST00000646948.1 [P24530-1] ENST00000643890.1 ENST00000475537.2 [P24530-1] A0A2R8Y748 ENST00000646607.2 [P24530-1] P24530 |